FindTrial
Sign In

Metabolic syndrome And Severity of Covid-19

Metabolic syndrome And Severity of Covid-19

Status
Recruiting
Phases
Unknown
Study type
Unknown
Source
NL-OMON
Registry ID
NL-OMON25762
Enrollment
100
Registered
2020-04-28
Start date
2020-04-28
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid-19 infection

Interventions

Any patient with a suspicion of covid-19 infection at the ER, the criteria of the metabolic syndrome were screened
glucose, hypertension (>130/85 mmHg and/ or medication), low HDL-cholesterol (men =1,04 mmmol/l
women = 1,29 mmol/l), high triglycerides (men and women = 1,7 mmol/l or statin use), abdominal obesity (hip and waist measurement in cm).

Sponsors

None
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age > 18 years old and no treatment restrictions

Exclusion criteria

Exclusion criteria: Patient not able to stand straight, this is necessary to measure the hip-waist ratio.

Design outcomes

Primary

MeasureTime frame
?- BMI ?- Hip- waist ratio ?- Covid-19 laboratory test (Ferritin, triglycerides, HDL-cholesterol, CRP, procalcitonin, ALAT, ASAT, GGT, AF, glucose, LDH, sodium, potassium ?- CT-scan; CO-RADS and severity score ?- Medication use (statins, inhalation corticosteroids, antihypertension medication etc.) ?- Severity of covid-19 infection defined by hospitalization, oxygen suppletion and intubation and ventilation at the intensive care. ?- Outcome after 30 days (complete recovery, rest abnormality, deceased)—

Secondary

MeasureTime frame
? - Diameter of fat on sternum (measuring on the CT at xyphoid)—

Contacts

Public ContactCathelijne van Zelst

Franciscus Gasthuis en Vlietland

c.zelst@franciscus.nl06-18975719

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)